CymitQuimica logo

CAS 900573-88-8

:

JI-101

Description:
JI-101, identified by its CAS number 900573-88-8, is a synthetic chemical compound that has garnered attention in various research fields, particularly in medicinal chemistry and materials science. While specific characteristics can vary based on its formulation and application, JI-101 is generally recognized for its unique molecular structure, which may confer specific biological or chemical properties. It is often studied for its potential therapeutic effects, possibly exhibiting activity against certain biological targets. Additionally, JI-101 may possess distinct physical properties such as solubility, stability, and reactivity, which are crucial for its application in drug development or as a functional material. As with many synthetic compounds, safety and handling guidelines are essential, and its toxicity profile would need to be evaluated in accordance with regulatory standards. Overall, JI-101 represents a compound of interest in ongoing research, with potential implications in various scientific and industrial applications.
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
  • JI-101

    CAS:
    Formula:C22H20BrN5O2
    Purity:98%
    Color and Shape:Solid
    Molecular weight:466.3305

    Ref: IN-DA00GU3U

    5mg
    129.00€
    10mg
    202.00€
    50mg
    181.00€
    100mg
    297.00€
  • JI-101

    CAS:
    JI-101
    Purity:≥98%
    Molecular weight:466.33g/mol

    Ref: 54-BUP12152

    1mg
    55.00€
    5mg
    109.00€
    10mg
    171.00€
    25mg
    272.00€
    50mg
    431.00€
    100mg
    660.00€
  • JI-101

    CAS:
    JI-101 (CGI-1842) is an oral multi-kinase inhibitor that targets VEGFR-2, PDGFR-β, and EphB4.
    Formula:C22H20BrN5O2
    Purity:99.41% - 99.97%
    Color and Shape:Solid
    Molecular weight:466.33
  • JI-101

    CAS:
    <p>JI-101 is a molecule that inhibits the production of growth factors by binding to their receptor. This drug is used in cancer treatment, and has shown anti-inflammatory effects in animal models of autoimmune diseases and inflammatory diseases. JI-101 inhibits the uptake of growth factors by cells, blocking their interaction with receptors on cell surfaces. The terminal half-life of JI-101 varies depending on the type of cancer and can range from 2 hours to more than 24 hours. It also has an acidic pH, which may make it more stable under conditions that cause degradation by alkaline conditions. It also binds to matrix components, inhibiting their activity and preventing them from binding to other molecules such as enzymes or hormones.<br>JI-101 is a potent inhibitor of angiogenesis, which is the formation of new blood vessels from pre-existing ones. This drug blocks the interactions between endothelial cells and VEGF, preventing the formation of new blood vessels that are vital for tumor growth.</p>
    Formula:C22H20BrN5O2
    Purity:Min. 95%
    Molecular weight:466.33 g/mol

    Ref: 3D-ALB57388

    25mg
    803.00€
    50mg
    1,210.00€
    100mg
    1,683.00€